Patent: 6,270,757
✉ Email this page to a colleague
Summary for Patent: 6,270,757
Title: | Formulations for IL-11 |
Abstract: | The present invention provides novel formulations comprising IL-11 and glycine. Also provided are compositions, both liquid and lyophilized, comprising IL-11 and glycine and optionally, a buffering agent such as histidine and phosphate. |
Inventor(s): | Warne; Nicholas W. (Methuen, MA) |
Assignee: | Genetics Institute, Inc. (Cambridge, MA) |
Application Number: | 08/230,982 |
Patent Claims: | see list of patent claims |
Details for Patent 6,270,757
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Wyeth Pharmaceuticals Inc. | NEUMEGA | oprelvekin | For Injection | 103694 | 11/25/1997 | ⤷ Try a Trial | 2039-03-29 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 6,270,757
Country | Patent Number | Estimated Expiration |
---|---|---|
World Intellectual Property Organization (WIPO) | 9528951 | ⤷ Try a Trial |
Japan | H09512529 | ⤷ Try a Trial |
Japan | 4118326 | ⤷ Try a Trial |
Japan | 2007217439 | ⤷ Try a Trial |
European Patent Office | 0758901 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |